In cancer cells treated with P2 peptides, Ago2 was disassociated from CAV1 on the plasma membranes, but Ago2 was still co-located with CAV1 on the plasma membrane of P2S-treated cancer cells (Fig. 2H). The gene discussed is AGO2; the disease is cancer.